Cardiovascular Revascularization Medicine
Volume 10, Issue 4 , Pages 216-220 , October 2009

Early and mid-term clinical outcomes with the CATANIA coronary stent system vs. bare metal stents in patients with coronary artery disease

  • Davide Capodanno

      Affiliations

    • Department of Cardiovascular Diseases, Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    • ETNA Foundation, Catania, Italy
    • Corresponding Author InformationCorresponding author. Ferrarotto Hospital, University of Catania, via Citelli 6, 95124 Catania, Italy. Tel.: +39 0957436201; fax: +39 095362429.
    • ,
  • Alessio La Manna

      Affiliations

    • Department of Cardiovascular Diseases, Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    • ,
  • Maria Elena Di Salvo

      Affiliations

    • Department of Cardiovascular Diseases, Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    • ,
  • Alessandra Sanfilippo

      Affiliations

    • Department of Cardiovascular Diseases, Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    • ,
  • Thierry Corcos

      Affiliations

    • Department of Interventional Cardiology, Clinique Turin, Paris, France
    • ,
  • Corrado Tamburino

      Affiliations

    • Department of Cardiovascular Diseases, Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
    • ETNA Foundation, Catania, Italy

Received 27 May 2009 ,Revised 30 June 2009 ,Accepted 7 July 2009.

References 

  1. Richter GM, Stampfl U, Stampfl S, Rehnitz C, Holler S, Schnabel P, et al. A new polymer concept for coating of vascular stents using PTFEP (poly(bis(trifluoroethoxy)phosphazene) to reduce thrombogenicity and late in-stent stenosis. Invest Radiol. 2005;40:210–218
  2. Tamburino C, La Manna A, Di Salvo ME, Sacchetta G, Capodanno D, Mehran R, et al. First-in-man one-year clinical outcomes of the CATANIA coronary stent system with nanothin Polyzene-F in de novo native coronary artery lesions: Assessment of The LAtest Non-Thrombogenic Angioplasty Stent (ATLANTA) Trial. J Am Coll Cardiol Intv. 2009;2:197–204
  3. Silber S, Albertsson P, Avilés FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804–847
  4. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351
  5. Ghali WA, Quan H, Brant R, van Melle G, Norris CM, Faris PD, et al. APPROACH (Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease) Investigators. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA. 2001;286:1494–1497
  6. Tamburino C, Di Salvo ME, Capodanno D, Marzocchi A, Sheiban I, Margheri M, et al. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry. Eur Heart J. 2009;30:1171–1179
  7. La Manna A, Capodanno D, Cera M, Di Salvo ME, Sacchetta G, Corcos T, et al. Optical coherence tomography results at six month follow-up evaluation of the CATANIA coronary stent system with nanothin Polyzene-F surface modification (from the Assessment of The LAtest Non-Thrombogenic Angioplasty Stent [ATLANTA] Trial). Am J Cardiol. 2009;103:1151–1155
  8. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–2441
  9. Radeleff B, Thierjung H, Stampfl U, Stampfl S, Lopez-Benitez R, Sommer C, et al. Restenosis of the CYPHER-Select, TAXUS-Express, and Polyzene-F nanocoated cobalt-chromium stents in the Minipig Coronary Artery Model. Cardiovasc Intervent Radiol. 2007;31:971–980
  10. Katritsis DG, Karvouni E, Ioannidis JP. Meta-analysis comparing drug-eluting stents with bare metal stents. Am J Cardiol. 2005;95(5):640–643
  11. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J. 2006;27(23):2784–2814

PII: S1553-8389(09)00242-5

doi: 10.1016/j.carrev.2009.07.001

Cardiovascular Revascularization Medicine
Volume 10, Issue 4 , Pages 216-220 , October 2009

Article Tools

* Image Usage & Resolution